Thomas Graff
Family Medicine · Whitehall, MINPI 1689665440
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.7% of the total across 291 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 12.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,305 and has fallen 99.3% since, to $17 in 2024. Among family medicine clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 291 payments — averaging $14.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$540
- Pfizer$532
- AstraZeneca$525
- GSK$369
- Lilly USA, LLC$338
- Novartis$184
- plus $2K from 24 others
What the payments were for
- Food & beverage$4,11198%
- Education$972%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 61 | $540 |
| Pfizer | 38 | $532 |
| AstraZeneca | 12 | $525 |
| GSK | 41 | $369 |
| Lilly USA, LLC | 29 | $338 |
| Novartis | 12 | $184 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $178 |
| Astellas Pharma US Inc | 6 | $174 |
| AbbVie(2 entities) | 11 | $161 |
| Boehringer Ingelheim | 11 | $156 |
| Mylan Specialty L.p. | 2 | $138 |
| Otsuka America Pharmaceutical, Inc. | 6 | $135 |
| Merck | 9 | $124 |
| Indivior Inc. | 3 | $95 |
| Amarin Pharma, Inc. | 6 | $93 |
| Amgen | 4 | $60 |
| Teva Pharmaceuticals USA, Inc. | 4 | $55 |
| Sanofi-aventis U.S. LLC | 3 | $55 |
| Johnson & Johnson | 5 | $53 |
| E.r. Squibb & Sons, L.L.C. | 3 | $38 |
| Ironshore Pharmaceuticals Inc. | 2 | $27 |
| Genentech USA, Inc. | 2 | $26 |
| Medical Device Business Services, Inc. | 1 | $24 |
| Shire North American Group Inc | 2 | $24 |
| Kowa Pharmaceuticals America, Inc. | 2 | $23 |
| Regeneron Healthcare Solutions, Inc. | 2 | $23 |
| Medtronic | 1 | $19 |
| Radius Health, Inc. | 1 | $14 |
| Lundbeck LLC | 1 | $14 |
| Circassia Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,208 in reported general payments places this provider in the 90th percentile of 3,945 family medicine providers in Michigan.
Other family medicine in Whitehall
- Loren ChudlerSouthfield$1.3M
- Paul BensonBerkley$779K
- Matt RosenbergJackson$550K
- Steve LasaterSaint Johns$291K
- Mary DagenGrand Rapids$265K
- Farhan BhattiLansing$230K
- Jeffrey DeitchSterling Heights$197K
- Sukhpreet SinghPlymouth$173K
- James VoigtOak Park$140K
- Timothy IzzoGrand Ledge$124K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.